HILLSIDE, N.J., April 13, 2009 (GLOBE NEWSWIRE) -- Integrated BioPharma, Inc. (the “Company”) (Pink Sheets:INBP) today announced that it has notified the NASDAQ Stock Market LLC its intention to voluntarily delist its common stock from the NASDAQ Global Market. The decision to voluntarily delist will eliminate listing fees and result in reduced expenses associated with compliance efforts, such as professional fees and administrative costs.
